199 related articles for article (PubMed ID: 35724697)
1. Comparison of commercial SARS-CoV-2 surrogate neutralization assays with a full virus endpoint dilution neutralization test in two different cohorts.
Adams O; Andrée M; Hermsen D; Lübke N; Timm J; Schaal H; Müller L
J Virol Methods; 2022 Sep; 307():114569. PubMed ID: 35724697
[TBL] [Abstract][Full Text] [Related]
2. Performance evaluation of four surrogate Virus Neutralization Tests (sVNTs) in comparison to the
Pieri M; Infantino M; Manfredi M; Nuccetelli M; Grossi V; Lari B; Tomassetti F; Sarubbi S; Russo E; Amedei A; Benucci M; Casprini P; Stacchini L; Castilletti C; Bernardini S
Front Biosci (Landmark Ed); 2022 Feb; 27(2):74. PubMed ID: 35227017
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a biotin-based surrogate virus neutralization test for detecting postvaccination antibodies against SARS-CoV-2 variants in sera.
Ahn MJ; Kang JA; Hong SM; Lee KS; Kim DH; Song D; Jeong DG
Biochem Biophys Res Commun; 2023 Feb; 646():8-18. PubMed ID: 36696754
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a Reference.
Graninger M; Jani CM; Reuberger E; Prüger K; Gaspar P; Springer DN; Borsodi C; Weidner L; Rabady S; Puchhammer-Stöckl E; Jungbauer C; Höltl E; Aberle JH; Stiasny K; Weseslindtner L
Microbiol Spectr; 2023 Feb; 11(1):e0231422. PubMed ID: 36622205
[TBL] [Abstract][Full Text] [Related]
5. A SARS-CoV-2 Label-Free Surrogate Virus Neutralization Test and a Longitudinal Study of Antibody Characteristics in COVID-19 Patients.
Luo YR; Yun C; Chakraborty I; Wu AHB; Lynch KL
J Clin Microbiol; 2021 Jun; 59(7):e0019321. PubMed ID: 33827900
[TBL] [Abstract][Full Text] [Related]
6. Two novel SARS-CoV-2 surrogate virus neutralization assays are suitable for assessing successful immunization with mRNA-1273.
Krüttgen A; Lauen M; Klingel H; Imöhl M; Kleines M
J Virol Methods; 2022 Jan; 299():114297. PubMed ID: 34563583
[TBL] [Abstract][Full Text] [Related]
7. Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera.
Oguntuyo KY; Stevens CS; Hung CT; Ikegame S; Acklin JA; Kowdle SS; Carmichael JC; Chiu HP; Azarm KD; Haas GD; Amanat F; Klingler J; Baine I; Arinsburg S; Bandres JC; Siddiquey MNA; Schilke RM; Woolard MD; Zhang H; ; Duty AJ; Kraus TA; Moran TM; Tortorella D; Lim JK; Gamarnik AV; Hioe CE; Zolla-Pazner S; Ivanov SS; Kamil JP; Krammer F; Lee B
mBio; 2021 Feb; 12(1):. PubMed ID: 33593976
[TBL] [Abstract][Full Text] [Related]
8. Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods.
Bošnjak B; Stein SC; Willenzon S; Cordes AK; Puppe W; Bernhardt G; Ravens I; Ritter C; Schultze-Florey CR; Gödecke N; Martens J; Kleine-Weber H; Hoffmann M; Cossmann A; Yilmaz M; Pink I; Hoeper MM; Behrens GMN; Pöhlmann S; Blasczyk R; Schulz TF; Förster R
Cell Mol Immunol; 2021 Apr; 18(4):936-944. PubMed ID: 33139905
[TBL] [Abstract][Full Text] [Related]
9. Reduced Binding between Omicron B.1.1.529 and the Human ACE2 Receptor in a Surrogate Virus Neutralization Test for SARS-CoV-2.
Hoffman T; Kolstad L; Akaberi D; Järhult JD; Rönnberg B; Lundkvist Å
Viruses; 2023 May; 15(6):. PubMed ID: 37376580
[TBL] [Abstract][Full Text] [Related]
10. A highly sensitive bead-based flow cytometric competitive binding assay to detect SARS-CoV-2 neutralizing antibody activity.
Yao X; Zhang Z; Mei Q; Li S; Xing L; Long Y; Zhang D; Wang J; Wang X; Xie B; Yang B; Gao Y; Wu C; Meng Q
Front Immunol; 2022; 13():1041860. PubMed ID: 36532082
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies.
Zedan HT; Yassine HM; Al-Sadeq DW; Liu N; Qotba H; Nicolai E; Pieri M; Bernardini S; Abu-Raddad LJ; Nasrallah GK
Sci Rep; 2022 Nov; 12(1):19020. PubMed ID: 36347859
[TBL] [Abstract][Full Text] [Related]
12. Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples.
Meyrath M; Szpakowska M; Plesseria JM; Domingues O; Langlet J; Weber B; Krüger R; Ollert M; Chevigné A;
Methods Enzymol; 2022; 675():351-381. PubMed ID: 36220277
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination Using a Multiplexed Surrogate Virus Neutralization Test.
Lynch KL; Zhou S; Kaul R; Walker R; Wu AH
Clin Chem; 2022 May; 68(5):702-712. PubMed ID: 35018416
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring.
Cristiano A; Pieri M; Sarubbi S; Pelagalli M; Calugi G; Tomassetti F; Bernardini S; Nuccetelli M
Clin Immunol; 2022 Jan; 234():108918. PubMed ID: 34971839
[TBL] [Abstract][Full Text] [Related]
15. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
[TBL] [Abstract][Full Text] [Related]
16. A New SARS-CoV-2 Dual-Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection.
Taylor SC; Hurst B; Charlton CL; Bailey A; Kanji JN; McCarthy MK; Morrison TE; Huey L; Annen K; DomBourian MG; Knight V
J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33500361
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays.
Sholukh AM; Fiore-Gartland A; Ford ES; Miner MD; Hou YJ; Tse LV; Kaiser H; Zhu H; Lu J; Madarampalli B; Park A; Lempp FA; St Germain R; Bossard EL; Kee JJ; Diem K; Stuart AB; Rupert PB; Brock C; Buerger M; Doll MK; Randhawa AK; Stamatatos L; Strong RK; McLaughlin C; Huang ML; Jerome KR; Baric RS; Montefiori D; Corey L
J Clin Microbiol; 2021 Sep; 59(10):e0052721. PubMed ID: 34288726
[TBL] [Abstract][Full Text] [Related]
18. RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers.
Aguilar R; Li X; Crowell CS; Burrell T; Vidal M; Rubio R; Jiménez A; Hernández-Luis P; Hofmann D; Mijočević H; Jeske S; Christa C; D'Ippolito E; Lingor P; Knolle PA; Roggendorf H; Priller A; Yazici S; Carolis C; Mayor A; Schreiner P; Poppert H; Beyer H; Schambeck SE; Izquierdo L; Tortajada M; Angulo A; Soutschek E; Engel P; Garcia-Basteiro A; Busch DH; Moncunill G; Protzer U; Dobaño C; Gerhard M
Microbiol Spectr; 2023 Feb; 11(1):e0316522. PubMed ID: 36622140
[TBL] [Abstract][Full Text] [Related]
19. A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies.
Pi-Estopiñan F; Pérez MT; Fraga A; Bergado G; Díaz GD; Orosa I; Díaz M; Solozábal JA; Rodríguez LM; Garcia-Rivera D; Macías C; Jerez Y; Casadesús AV; Fernández-Marrero B; Bermúdez E; Plasencia CA; Sánchez B; Hernández T
Vaccine; 2022 Mar; 40(13):1958-1967. PubMed ID: 35193792
[TBL] [Abstract][Full Text] [Related]
20. Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding Domain.
Lee B; Ko JH; Lee KH; Kim YC; Song YG; Park YS; Baek YJ; Ahn JY; Choi JY; Song KH; Kim ES; Bae S; Kim SH; Jeong HW; Kim SW; Kwon KT; Kim SH; Jeong H; Kim B; Kim SS; Choi WS; Peck KR; Kang ES
Microbiol Spectr; 2022 Dec; 10(6):e0266922. PubMed ID: 36250875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
